PEPL is readying for a comeback. It has a well-diversified model with strong mix of annuity & residential asset. Moat lies in acquiring land at...
Stylam has strong revenue visibility from upcoming plant. Mgmnt is targeting to double revenue in 4 years. Govt may levy anti-dumping duty on...
Radico Khaitan is a high-conviction buy. Good times are here to stay. Co is likely to be significant beneficiary of UP's new excise policy for...
Quess Corp has value creation via formalisation & demerger. The demerger into 3 independent entities will result in (1) value unlocking for each...
IPCA Labs’ brand-building strength will drive outperformance. Synergies from Unichem integration will accelerate earnings. IPCA will trade at...
The fit between Sudarshan & Heubach is perfect. Having a global scale is essential for success in the pigment business. Sudarshan has access to...
Thangamayil Jewellery is a high-conviction BUY. It is the D-Mart of Tamil Nadu's jewellery retail sector. Significant rerating is expected as the...
Stylam is top pick in building materials. It has industry-leading growth (~2x vs industry), EBITDA margin (~20%), healthy balance sheet (net cash)...
GAIL is trading at 11.6x Mar-26E EPS, only 1% premium to five-year average despite stronger volume growth outlook in core business of gas...
Federal Bank has broken through midsized banks league. It has a shock-proof balance sheet. Key challenge lies in leveraging its formidable balance...
Thangamayil Jewellery is entering a golden era & is a high-conviction buy. It is the D-Mart of the jewellery retail sector. ROE will improve to...
MCX commodity F&O options volumes are witnessing strong growth but is still in its infancy when compared to equity derivative markets. MCX will...
Sobha has operational excellence & market leadership with a vision of market expansion. Demand is robust. Top-notch execution to drive pricing...
Investment implications: We reiterate our conviction on banks with a strong balance sheet and formidable retail deposit franchise, which are...
A sharp surge in ROIC: Jyothy Labs’ ROIC has sharply surged, moving up from c17% in FY23 to c28% FY24, owing to a sharp spike in EBIT margin (up...
5 Top Pharma picks. Pharma sector is now on a recovery path due to moderating price erosion & USFDA regulatory issues. Costs are stabilizing....
MCX is making a new beginning. It has successfully executed a complex transition. Options volume has increased by 4x YoY & is currently >INR...
Top picks of Bank and NBFC/HFC stocks. The froth is in unsecured “small-ticket personal loans” category. Given the RBI’s hawk-eye focus on this...
Nifty & Bank Nifty analysis: Downside is limited. Nifty Futures’ open Interest is higher. FII's long to short ratio in Index Futures is 2.28. FIIs...
Stylam Industries has industry-leading growth (~2x vs industry), EBITDA margin (~20%), healthy balance sheet (net cash) & impressive return ratio...
Separate names with a comma.
